CLINICAL_TRIALS
trial_result
· 2017-01-05
Clinical Trial Update: Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma [Phase 2]
Summary
A Phase 2 trial evaluating dose-escalated MR spectroscopy imaging-guided radiation therapy for glioblastoma has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Miami | Conditions: Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2017-01-05